Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
At StockStory, we look beyond the headlines with our independent analysis to determine whether these bearish calls are justified. Keeping that in mind, here are three stocks where the skepticism is well-placed and some better opportunities to consider.
Acadia Healthcare (ACHC)
Consensus Price Target: $22.71 (-17.7% implied return)
With a network of over 250 facilities serving patients in 38 states and Puerto Rico, Acadia Healthcare (NASDAQ: ACHC) operates facilities providing mental health and substance use disorder treatment services across the United States.
Why Do We Avoid ACHC?
- Weak admissions over the past two years show it’s struggled to increase its sales volumes and had to rely on price increases
- Incremental sales over the last five years were much less profitable as its earnings per share fell by 6.1% annually while its revenue grew
- Free cash flow margin dropped by 18.9 percentage points over the last five years, implying the company became more capital intensive as competition picked up
Acadia Healthcare’s stock price of $27.60 implies a valuation ratio of 17.6x forward P/E. Read our free research report to see why you should think twice about including ACHC in your portfolio.
BNY (BK)
Consensus Price Target: $133.50 (3.8% implied return)
Tracing its roots back to 1784 when it was founded by Alexander Hamilton, BNY (NYSE: BK) is a global financial institution that provides asset servicing, wealth management, and investment services to institutions, corporations, and high-net-worth individuals.
Why Is BK Not Exciting?
- The company has faced growth challenges as its 4.7% annual revenue increases over the last five years fell short of other financials companies
- Sizable asset base leads to capital growth challenges as its 3.2% annual tangible book value per share increases over the last five years fell short of other financials companies
- Low return on equity reflects management’s struggle to allocate funds effectively
At $128.62 per share, BNY trades at 15.1x forward P/E. Check out our free in-depth research report to learn more about why BK doesn’t pass our bar.
Kodiak Gas Services (KGS)
Consensus Price Target: $55.83 (-7.6% implied return)
Dominating the Permian Basin with a fleet focused on large horsepower units exceeding 1,000 horsepower each, Kodiak Gas Services (NYSE: KGS) operates compression equipment that maintains natural gas pressure for production, gathering, and transportation.
Why Are We Wary of KGS?
- Modest revenue base of $1.31 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Costs have risen faster than its revenue over the last five years, causing its EBITDA margin to decline by 4.9 percentage points
- Low free cash flow margin of 7.1% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
Kodiak Gas Services is trading at $60.46 per share, or 22.5x forward P/E. Read our free research report to see why you should think twice about including KGS in your portfolio.
Stocks We Like More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
